世界のバイオシミラーモノクローナル抗体市場：専門的調査

• 英文タイトル：Global Biosimilar Monoclonal Antibodies Market Professional Survey Report 2019

• レポートコード：QYR9ST07432
• 出版社/出版日：QYResearch / 2019年9月5日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、106ページ
• 納品方法：Eメール（受注後2-3営業日）
• 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥518,000 (USD3,500)	▷ お問い合わせ
Enterprise License	￥1,036,000 (USD7,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

※本調査レポートは、バイオシミラーモノクローナル抗体の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、インフリキシマブ、リツキシマブ、トラスツズマブ、アダリムマブ、その他に、用途別には、腫瘍学、自己免疫疾患、その他にセグメント区分し、バイオシミラーモノクローナル抗体の世界市場を分析しました。

・エグゼクティブ・サマリー
・バイオシミラーモノクローナル抗体の世界市場概要
・バイオシミラーモノクローナル抗体の製造コスト構成分析
・バイオシミラーモノクローナル抗体の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・バイオシミラーモノクローナル抗体の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・バイオシミラーモノクローナル抗体のセグメント分析（種類別）
（インフリキシマブ、リツキシマブ、トラスツズマブ、アダリムマブ、その他）
・バイオシミラーモノクローナル抗体のセグメント分析（用途別）
（腫瘍学、自己免疫疾患、その他）
・バイオシミラーモノクローナル抗体の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Celltrion、Pfizer (Hospira)、3SBIO、Novartis (Sandoz)、Dr Reddy’s、Celgen Biopharma、Cadila Healthcare、Hisun Pharma、Torrent Pharmaceuticals）
・バイオシミラーモノクローナル抗体の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...

Monoclonal antibodies (mAb) are antibodies produced by using identical immune cells that are clones of one unique parent cell. Since monoclonal antibodies are produced from clones of only one parent cell, all monoclonal antibodies produced by the parent cell are the same due to which, they are called biosimilar monoclonal antibodies.The classification of Biosimilar Monoclonal Antibodies includes Infliximab, Rituximab, Trastuzumab, Adalimumab and Other, and the sales proportion of Infliximab in 2017 is about 36.5%.
Biosimilar Monoclonal Antibodies is widely used for Oncology, Autoimmune Disease and Others. The most proportion of Biosimilar Monoclonal Antibodies is sales in Autoimmune Disease, and the consumption proportion is about 85.6% in 2017.

The global Biosimilar Monoclonal Antibodies market was valued at 2750 million US$ in 2018 and will reach 15200 million US$ by the end of 2025, growing at a CAGR of 27.7% during 2019-2025.
This report focuses on Biosimilar Monoclonal Antibodies volume and value at global level, regional level and company level. From a global perspective, this report represents overall Biosimilar Monoclonal Antibodies market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Biosimilar Monoclonal Antibodies in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Biosimilar Monoclonal Antibodies manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Celltrion
Pfizer (Hospira)
3SBIO
Novartis (Sandoz)
Dr Reddy’s
Celgen Biopharma
Cadila Healthcare
Hisun Pharma
Torrent Pharmaceuticals

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Infliximab
Rituximab
Trastuzumab
Adalimumab
Other

Segment by Application
Oncology
Autoimmune Disease
Other

レポート目次

Table of Contents

Executive Summary
1 Industry Overview of Biosimilar Monoclonal Antibodies
1.1 Definition of Biosimilar Monoclonal Antibodies
1.2 Biosimilar Monoclonal Antibodies Segment by Type
1.2.1 Global Biosimilar Monoclonal Antibodies Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Infliximab
1.2.3 Rituximab
1.2.4 Trastuzumab
1.2.5 Adalimumab
1.2.6 Other
1.3 Biosimilar Monoclonal Antibodies Segment by Applications
1.3.1 Global Biosimilar Monoclonal Antibodies Consumption Comparison by Applications (2014-2025)
1.3.2 Oncology
1.3.3 Autoimmune Disease
1.3.4 Other
1.4 Global Biosimilar Monoclonal Antibodies Overall Market
1.4.1 Global Biosimilar Monoclonal Antibodies Revenue (2014-2025)
1.4.2 Global Biosimilar Monoclonal Antibodies Production (2014-2025)
1.4.3 North America Biosimilar Monoclonal Antibodies Status and Prospect (2014-2025)
1.4.4 Europe Biosimilar Monoclonal Antibodies Status and Prospect (2014-2025)
1.4.5 China Biosimilar Monoclonal Antibodies Status and Prospect (2014-2025)
1.4.6 Japan Biosimilar Monoclonal Antibodies Status and Prospect (2014-2025)
1.4.7 Southeast Asia Biosimilar Monoclonal Antibodies Status and Prospect (2014-2025)
1.4.8 India Biosimilar Monoclonal Antibodies Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Biosimilar Monoclonal Antibodies
2.3 Manufacturing Process Analysis of Biosimilar Monoclonal Antibodies
2.4 Industry Chain Structure of Biosimilar Monoclonal Antibodies

3 Development and Manufacturing Plants Analysis of Biosimilar Monoclonal Antibodies
3.1 Capacity and Commercial Production Date
3.2 Global Biosimilar Monoclonal Antibodies Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Biosimilar Monoclonal Antibodies
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Biosimilar Monoclonal Antibodies Production and Capacity Analysis
4.2 Biosimilar Monoclonal Antibodies Revenue Analysis
4.3 Biosimilar Monoclonal Antibodies Price Analysis
4.4 Market Concentration Degree

5 Biosimilar Monoclonal Antibodies Regional Market Analysis
5.1 Biosimilar Monoclonal Antibodies Production by Regions
5.1.1 Global Biosimilar Monoclonal Antibodies Production by Regions
5.1.2 Global Biosimilar Monoclonal Antibodies Revenue by Regions
5.2 Biosimilar Monoclonal Antibodies Consumption by Regions
5.3 North America Biosimilar Monoclonal Antibodies Market Analysis
5.3.1 North America Biosimilar Monoclonal Antibodies Production
5.3.2 North America Biosimilar Monoclonal Antibodies Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Biosimilar Monoclonal Antibodies Import and Export
5.4 Europe Biosimilar Monoclonal Antibodies Market Analysis
5.4.1 Europe Biosimilar Monoclonal Antibodies Production
5.4.2 Europe Biosimilar Monoclonal Antibodies Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Biosimilar Monoclonal Antibodies Import and Export
5.5 China Biosimilar Monoclonal Antibodies Market Analysis
5.5.1 China Biosimilar Monoclonal Antibodies Production
5.5.2 China Biosimilar Monoclonal Antibodies Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Biosimilar Monoclonal Antibodies Import and Export
5.6 Japan Biosimilar Monoclonal Antibodies Market Analysis
5.6.1 Japan Biosimilar Monoclonal Antibodies Production
5.6.2 Japan Biosimilar Monoclonal Antibodies Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Biosimilar Monoclonal Antibodies Import and Export
5.7 Southeast Asia Biosimilar Monoclonal Antibodies Market Analysis
5.7.1 Southeast Asia Biosimilar Monoclonal Antibodies Production
5.7.2 Southeast Asia Biosimilar Monoclonal Antibodies Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Biosimilar Monoclonal Antibodies Import and Export
5.8 India Biosimilar Monoclonal Antibodies Market Analysis
5.8.1 India Biosimilar Monoclonal Antibodies Production
5.8.2 India Biosimilar Monoclonal Antibodies Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Biosimilar Monoclonal Antibodies Import and Export

6 Biosimilar Monoclonal Antibodies Segment Market Analysis (by Type)
6.1 Global Biosimilar Monoclonal Antibodies Production by Type
6.2 Global Biosimilar Monoclonal Antibodies Revenue by Type
6.3 Biosimilar Monoclonal Antibodies Price by Type

7 Biosimilar Monoclonal Antibodies Segment Market Analysis (by Application)
7.1 Global Biosimilar Monoclonal Antibodies Consumption by Application
7.2 Global Biosimilar Monoclonal Antibodies Consumption Market Share by Application (2014-2019)

8 Biosimilar Monoclonal Antibodies Major Manufacturers Analysis
8.1 Celltrion
8.1.1 Celltrion Biosimilar Monoclonal Antibodies Production Sites and Area Served
8.1.2 Celltrion Product Introduction, Application and Specification
8.1.3 Celltrion Biosimilar Monoclonal Antibodies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Pfizer (Hospira)
8.2.1 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Production Sites and Area Served
8.2.2 Pfizer (Hospira) Product Introduction, Application and Specification
8.2.3 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 3SBIO
8.3.1 3SBIO Biosimilar Monoclonal Antibodies Production Sites and Area Served
8.3.2 3SBIO Product Introduction, Application and Specification
8.3.3 3SBIO Biosimilar Monoclonal Antibodies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Novartis (Sandoz)
8.4.1 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Production Sites and Area Served
8.4.2 Novartis (Sandoz) Product Introduction, Application and Specification
8.4.3 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Dr Reddy’s
8.5.1 Dr Reddy’s Biosimilar Monoclonal Antibodies Production Sites and Area Served
8.5.2 Dr Reddy’s Product Introduction, Application and Specification
8.5.3 Dr Reddy’s Biosimilar Monoclonal Antibodies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Celgen Biopharma
8.6.1 Celgen Biopharma Biosimilar Monoclonal Antibodies Production Sites and Area Served
8.6.2 Celgen Biopharma Product Introduction, Application and Specification
8.6.3 Celgen Biopharma Biosimilar Monoclonal Antibodies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Cadila Healthcare
8.7.1 Cadila Healthcare Biosimilar Monoclonal Antibodies Production Sites and Area Served
8.7.2 Cadila Healthcare Product Introduction, Application and Specification
8.7.3 Cadila Healthcare Biosimilar Monoclonal Antibodies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Hisun Pharma
8.8.1 Hisun Pharma Biosimilar Monoclonal Antibodies Production Sites and Area Served
8.8.2 Hisun Pharma Product Introduction, Application and Specification
8.8.3 Hisun Pharma Biosimilar Monoclonal Antibodies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Torrent Pharmaceuticals
8.9.1 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Production Sites and Area Served
8.9.2 Torrent Pharmaceuticals Product Introduction, Application and Specification
8.9.3 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served

9 Development Trend of Analysis of Biosimilar Monoclonal Antibodies Market
9.1 Global Biosimilar Monoclonal Antibodies Market Trend Analysis
9.1.1 Global Biosimilar Monoclonal Antibodies Market Size (Volume and Value) Forecast 2019-2025
9.2 Biosimilar Monoclonal Antibodies Regional Market Trend
9.2.1 North America Biosimilar Monoclonal Antibodies Forecast 2019-2025
9.2.2 Europe Biosimilar Monoclonal Antibodies Forecast 2019-2025
9.2.3 China Biosimilar Monoclonal Antibodies Forecast 2019-2025
9.2.4 Japan Biosimilar Monoclonal Antibodies Forecast 2019-2025
9.2.5 Southeast Asia Biosimilar Monoclonal Antibodies Forecast 2019-2025
9.2.6 India Biosimilar Monoclonal Antibodies Forecast 2019-2025
9.3 Biosimilar Monoclonal Antibodies Market Trend (Product Type)
9.4 Biosimilar Monoclonal Antibodies Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Biosimilar Monoclonal Antibodies Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Biosimilar Monoclonal Antibodies
Table Global Biosimilar Monoclonal Antibodies Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Biosimilar Monoclonal Antibodies Production Market Share by Types in 2018
Figure Infliximab Product Picture
Figure Rituximab Product Picture
Figure Trastuzumab Product Picture
Figure Adalimumab Product Picture
Figure Other Product Picture
Table Global Biosimilar Monoclonal Antibodies Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Biosimilar Monoclonal Antibodies Consumption Market Share by Applications in 2018
Figure Oncology
Figure Autoimmune Disease
Figure Other
Figure Global Biosimilar Monoclonal Antibodies Revenue (Million USD) (2014-2025)
Figure Global Biosimilar Monoclonal Antibodies Production (K Units) (2014-2025)
Figure North America Biosimilar Monoclonal Antibodies Market Size (Million USD) (2014-2025)
Figure Europe Biosimilar Monoclonal Antibodies Market Size (Million USD) (2014-2025)
Figure China Biosimilar Monoclonal Antibodies Market Size (Million USD) (2014-2025)
Figure Japan Biosimilar Monoclonal Antibodies Market Size (Million USD) (2014-2025)
Figure Southeast Asia Biosimilar Monoclonal Antibodies Market Size (Million USD) (2014-2025)
Figure India Biosimilar Monoclonal Antibodies Market Size (Million USD) (2014-2025)
Table Biosimilar Monoclonal Antibodies Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Biosimilar Monoclonal Antibodies in 2018
Figure Manufacturing Process Analysis of Biosimilar Monoclonal Antibodies
Figure Industry Chain Structure of Biosimilar Monoclonal Antibodies
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Biosimilar Monoclonal Antibodies Manufacturing Plants Distribution
Table Biosimilar Monoclonal Antibodies Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Biosimilar Monoclonal Antibodies Capacity (K Units) of Major Manufacturers (2014-2019)
Table Biosimilar Monoclonal Antibodies Production (K Units) of Major Manufacturers (2014-2019)
Table Biosimilar Monoclonal Antibodies Production Market Share of Major Manufacturers (2014-2019)
Figure Biosimilar Monoclonal Antibodies Production Share by Manufacturers in 2018
Table Biosimilar Monoclonal Antibodies Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Biosimilar Monoclonal Antibodies Revenue Market Share of Major Manufacturers (2014-2019)
Figure Biosimilar Monoclonal Antibodies Revenue Share by Manufacturers in 2018
Table Biosimilar Monoclonal Antibodies Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Biosimilar Monoclonal Antibodies Production by Regions 2014-2019 (K Units)
Table Global Biosimilar Monoclonal Antibodies Production Market Share by Regions 2014-2019
Figure Global Biosimilar Monoclonal Antibodies Production Market Share by Regions in 2018
Table Global Biosimilar Monoclonal Antibodies Revenue by Regions 2014-2019 (Million USD)
Table Global Biosimilar Monoclonal Antibodies Revenue Market Share by Regions 2014-2019
Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Regions in 2018
Table Global Biosimilar Monoclonal Antibodies Consumption by Regions 2014-2019 (K Units)
Table Global Biosimilar Monoclonal Antibodies Consumption Market Share by Regions 2014-2019
Figure North America Biosimilar Monoclonal Antibodies Production Growth Rate 2014-2019 (K Units)
Figure North America Biosimilar Monoclonal Antibodies Revenue Growth Rate 2014-2019 (Million USD)
Table North America Biosimilar Monoclonal Antibodies Production, Consumption Import and Export (K Units)
Figure Europe Biosimilar Monoclonal Antibodies Production Growth Rate 2014-2019 (K Units)
Figure Europe Biosimilar Monoclonal Antibodies Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Biosimilar Monoclonal Antibodies Production, Consumption Import and Export (K Units)
Figure China Biosimilar Monoclonal Antibodies Production Growth Rate 2014-2019 (K Units)
Figure China Biosimilar Monoclonal Antibodies Revenue Growth Rate 2014-2019 (Million USD)
Table China Biosimilar Monoclonal Antibodies Production, Consumption Import and Export (K Units)
Figure Japan Biosimilar Monoclonal Antibodies Production Growth Rate 2014-2019 (K Units)
Figure Japan Biosimilar Monoclonal Antibodies Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Biosimilar Monoclonal Antibodies Production, Consumption Import and Export (K Units)
Figure Southeast Asia Biosimilar Monoclonal Antibodies Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Biosimilar Monoclonal Antibodies Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Biosimilar Monoclonal Antibodies Production, Consumption Import and Export (K Units)
Figure India Biosimilar Monoclonal Antibodies Production Growth Rate 2014-2019 (K Units)
Figure India Biosimilar Monoclonal Antibodies Revenue Growth Rate 2014-2019 (Million USD)
Table India Biosimilar Monoclonal Antibodies Production, Consumption Import and Export (K Units)
Figure Global Consumption Biosimilar Monoclonal Antibodies Market Share by Application (2014-2019)
Figure Global Value (Consumption) Biosimilar Monoclonal Antibodies Market Share by Application (2014-2019)
Table Celltrion Biosimilar Monoclonal Antibodies Production Sites and Area Served
Table Celltrion Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification
Table Celltrion Biosimilar Monoclonal Antibodies Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Celltrion Biosimilar Monoclonal Antibodies Production Growth Rate (2014-2019)
Table Celltrion Biosimilar Monoclonal Antibodies Production Market Share (2014-2019)
Figure Celltrion Biosimilar Monoclonal Antibodies Revenue Market Share (2014-2019)
Table Celltrion Biosimilar Monoclonal Antibodies Main Business and Markets Served
Table Pfizer (Hospira) Biosimilar Monoclonal Antibodies Production Sites and Area Served
Table Pfizer (Hospira) Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification
Table Pfizer (Hospira) Biosimilar Monoclonal Antibodies Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer (Hospira) Biosimilar Monoclonal Antibodies Production Growth Rate (2014-2019)
Table Pfizer (Hospira) Biosimilar Monoclonal Antibodies Production Market Share (2014-2019)
Figure Pfizer (Hospira) Biosimilar Monoclonal Antibodies Revenue Market Share (2014-2019)
Table Pfizer (Hospira) Biosimilar Monoclonal Antibodies Main Business and Markets Served
Table 3SBIO Biosimilar Monoclonal Antibodies Production Sites and Area Served
Table 3SBIO Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification
Table 3SBIO Biosimilar Monoclonal Antibodies Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table 3SBIO Biosimilar Monoclonal Antibodies Production Growth Rate (2014-2019)
Table 3SBIO Biosimilar Monoclonal Antibodies Production Market Share (2014-2019)
Figure 3SBIO Biosimilar Monoclonal Antibodies Revenue Market Share (2014-2019)
Table 3SBIO Biosimilar Monoclonal Antibodies Main Business and Markets Served
Table Novartis (Sandoz) Biosimilar Monoclonal Antibodies Production Sites and Area Served
Table Novartis (Sandoz) Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification
Table Novartis (Sandoz) Biosimilar Monoclonal Antibodies Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis (Sandoz) Biosimilar Monoclonal Antibodies Production Growth Rate (2014-2019)
Table Novartis (Sandoz) Biosimilar Monoclonal Antibodies Production Market Share (2014-2019)
Figure Novartis (Sandoz) Biosimilar Monoclonal Antibodies Revenue Market Share (2014-2019)
Table Novartis (Sandoz) Biosimilar Monoclonal Antibodies Main Business and Markets Served
Table Dr Reddy’s Biosimilar Monoclonal Antibodies Production Sites and Area Served
Table Dr Reddy’s Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification
Table Dr Reddy’s Biosimilar Monoclonal Antibodies Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Dr Reddy’s Biosimilar Monoclonal Antibodies Production Growth Rate (2014-2019)
Table Dr Reddy’s Biosimilar Monoclonal Antibodies Production Market Share (2014-2019)
Figure Dr Reddy’s Biosimilar Monoclonal Antibodies Revenue Market Share (2014-2019)
Table Dr Reddy’s Biosimilar Monoclonal Antibodies Main Business and Markets Served
Table Celgen Biopharma Biosimilar Monoclonal Antibodies Production Sites and Area Served
Table Celgen Biopharma Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification
Table Celgen Biopharma Biosimilar Monoclonal Antibodies Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Celgen Biopharma Biosimilar Monoclonal Antibodies Production Growth Rate (2014-2019)
Table Celgen Biopharma Biosimilar Monoclonal Antibodies Production Market Share (2014-2019)
Figure Celgen Biopharma Biosimilar Monoclonal Antibodies Revenue Market Share (2014-2019)
Table Celgen Biopharma Biosimilar Monoclonal Antibodies Main Business and Markets Served
Table Cadila Healthcare Biosimilar Monoclonal Antibodies Production Sites and Area Served
Table Cadila Healthcare Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification
Table Cadila Healthcare Biosimilar Monoclonal Antibodies Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Cadila Healthcare Biosimilar Monoclonal Antibodies Production Growth Rate (2014-2019)
Table Cadila Healthcare Biosimilar Monoclonal Antibodies Production Market Share (2014-2019)
Figure Cadila Healthcare Biosimilar Monoclonal Antibodies Revenue Market Share (2014-2019)
Table Cadila Healthcare Biosimilar Monoclonal Antibodies Main Business and Markets Served
Table Hisun Pharma Biosimilar Monoclonal Antibodies Production Sites and Area Served
Table Hisun Pharma Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification
Table Hisun Pharma Biosimilar Monoclonal Antibodies Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Hisun Pharma Biosimilar Monoclonal Antibodies Production Growth Rate (2014-2019)
Table Hisun Pharma Biosimilar Monoclonal Antibodies Production Market Share (2014-2019)
Figure Hisun Pharma Biosimilar Monoclonal Antibodies Revenue Market Share (2014-2019)
Table Hisun Pharma Biosimilar Monoclonal Antibodies Main Business and Markets Served
Table Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Production Sites and Area Served
Table Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification
Table Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Production Growth Rate (2014-2019)
Table Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Production Market Share (2014-2019)
Figure Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Revenue Market Share (2014-2019)
Table Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Main Business and Markets Served
Figure Global Biosimilar Monoclonal Antibodies Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Biosimilar Monoclonal Antibodies Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Biosimilar Monoclonal Antibodies Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Biosimilar Monoclonal Antibodies Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Biosimilar Monoclonal Antibodies Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Biosimilar Monoclonal Antibodies Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Biosimilar Monoclonal Antibodies Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Biosimilar Monoclonal Antibodies Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Biosimilar Monoclonal Antibodies Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Biosimilar Monoclonal Antibodies Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Biosimilar Monoclonal Antibodies Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Biosimilar Monoclonal Antibodies Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Biosimilar Monoclonal Antibodies Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Biosimilar Monoclonal Antibodies Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Biosimilar Monoclonal Antibodies Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Biosimilar Monoclonal Antibodies by Type (2019-2025)
Table Global Consumption (K Units) of Biosimilar Monoclonal Antibodies by Application (2019-2025)
Table Biosimilar Monoclonal Antibodies Distributors List
Table Biosimilar Monoclonal Antibodies Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

バイオシミラーモノクローナル抗体の世界市場：市場規模・現状・予測

Global Biosimilar Monoclonal Antibody Market Size, Status and Forecast 2019-2025
QYR9ST03834 2019年9月2日 92Pages
※当調査レポートでは、バイオシミラーモノクローナル抗体の世界市場について調査・分析し、バイオシミラーモノクローナル抗体の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（合成化学、バイオ製薬、その他）、...

がんモノクローナル抗体の世界市場：インサイト・予測

Global Cancer Monoclonal Antibodies Market Insights, Forecast to 2025
QYR9ST01381 2019年9月2日 111Pages
※本調査レポートでは、世界のがんモノクローナル抗体市場について調査・分析し、以下の構成でお届け致します。がんモノクローナル抗体の種類別には、マウス抗体、キメラおよびヒト化抗体、完全ヒト化抗体、その他に、用途別には、肝臓、乳房、血液、脳、ホジキンおよび非ホジキンリンパ腫、結腸直腸、白血病、その他に、地...

乳がんモノクローナル抗体の世界市場：市場規模・現状・予測

Global Breast Cancer Monoclonal Antibodies Market Size, Status and Forecast 2019-2025
QYR9ST03163 2019年9月2日 100Pages
※当調査レポートでは、乳がんモノクローナル抗体の世界市場について調査・分析し、乳がんモノクローナル抗体の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ネイキッド型MAbs、抱合型Mabs）、用途別（...

バイオシミラーの世界市場：インサイト・予測

Global Biosimilar Market Insights, Forecast to 2025
QYR9ST00380 2019年9月2日 113Pages
※本調査レポートでは、世界のバイオシミラー市場について調査・分析し、以下の構成でお届け致します。バイオシミラーの種類別には、人間用成長ホルモン、モノクローナル抗体、インスリン、ペプチド、エリスロポエチン、その他に、用途別には、腫瘍学、慢性および自己免疫疾患、成長ホルモン欠乏症、感染症、その他に、地域...

バイオシミラー試験・開発サービスの世界市場：市場規模・現状・予測

Global Biosimilar Testing and Development Services Market Size, Status and Forecast 2019-2025
QYR9ST04391 2019年9月2日 96Pages
※当調査レポートでは、バイオシミラー試験・開発サービスの世界市場について調査・分析し、バイオシミラー試験・開発サービスの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（エフェクター結合、ELISA、速...

レミケードバイオシミラーの世界市場：インサイト・予測

Global Remicade Biosimilar Market Insights, Forecast to 2025
QYR9ST03014 2019年9月2日 114Pages
※本調査レポートでは、世界のレミケードバイオシミラー市場について調査・分析し、以下の構成でお届け致します。レミケードバイオシミラーの種類別には、100mg/10ml、500mg/50mlに、用途別には、血液疾患、腫瘍疾患に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド...

世界のハーセプチンバイオシミラー市場：専門的調査

Global Herceptin Biosimilar Market Professional Survey Report 2019
QYR9ST06057 2019年9月2日 102Pages
※本調査レポートは、ハーセプチンバイオシミラーの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、乳癌、大腸癌、白血病、リンパ腫、その他に、用途別には、病院及びク...

世界のハーセプチンバイオシミラー市場：専門的調査

世界の小分子抗体市場：専門的調査

Global Small Molecule Antibodies Market Professional Survey Report 2019
QYR9ST09373 2019年9月5日 108Pages
※本調査レポートは、小分子抗体の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ウサギモノクローナルタイプ、その他に、用途別には、小分子バイオマーカー検出、小分...

組換え治療用抗体及びタンパク質の世界市場：インサイト・予測

Global Recombinant Therapeutic Antibodies and Proteins Market Insights, Forecast to 2025
QYR9ST00658 2019年9月2日 112Pages
※本調査レポートでは、世界の組換え治療用抗体及びタンパク質市場について調査・分析し、以下の構成でお届け致します。組換え治療用抗体及びタンパク質の種類別には、血漿タンパク質、融合タンパク質、モノクローナル抗体、ホルモン、酵素、凝固因子、その他に、用途別には、腫瘍学、血液学、免疫学、内分泌学、感染症、心...

バイオシミラーモノクローナル抗体の世界市場：市場規模・現状・予測 Biosimilar monoclonal antibodies (mAbs) are complex, large proteins of the biosimilar family used by the immune system to identify and neutralize foreign bodies, such as bacteria, viruses, and others. These antibodies are normally administered in the treatment of diseases such as rheumatoid arthriti…
がんモノクローナル抗体の世界市場：インサイト・予測 The mAbs, which are produced by genetic engineering, target antigens in cells, tissues, and organs. They are used in clinical applications to treat diseases with excellent efficacy and minimal side effects. Their MOA, absence of generic pathway, and therapeutic applications distinguish them from oth…
乳がんモノクローナル抗体の世界市場：市場規模・現状・予測 Breast cancer is characterized by the malignancy of cells in the tissues of the breast. HER-2 breast cancer is the most common type of breast cancer. The HER-2 protein, present on the surface of normal breast cells, affects the growth of the malignant cells. The uncontrolled synthesis of this protei…
バイオシミラーの世界市場：インサイト・予測 A product is termed as biosimilar product, if it is a biological product with similar characteristics as that of a reference biological product, which possesses approval from agencies such as FDA. There would not be any major clinical difference in effectiveness and safety as that of reference produ…
バイオシミラー試験・開発サービスの世界市場：市場規模・現状・予測 The global biosimilar testing and development services is segmented on the basis of clinical assays, comparability testing, and region. On the basis of clinical assays, it is divided into PK assay, tiered immunogenicity testing, and NAb assays. On the basis of comparability testing, it is classified…